NCT02843698View on ClinicalTrials.gov

Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

August 26, 2017

Study Completion Date

August 26, 2017

Conditions
Restrictive Lung Disease
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine infusion was previously reported to improve oxygenation and lung dynamics in patients with obstructive lung diseases. In our study we are going to investigate its effect on oxygenation and lung dynamics in restrictive lung disease

DRUG

Normal saline

Normal saline

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02843698 - Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations | Biotech Hunter | Biotech Hunter